What does a medical science liaison do? Role, requirements and salary in Australia

Published on September 14, 2026

Written / Hosted by: Elizabeth Pettit

A medical science liaison (MSL) is the scientific face of a pharmaceutical or biotech company in the field: a medical affairs professional who builds peer-to-peer relationships with key opinion leaders, clinicians and researchers, exchanging scientific evidence about disease areas and therapies in a strictly non-promotional capacity. In Australia, MSLs typically hold a PhD, PharmD, medical degree or strong postgraduate science qualifications, often with clinical or research experience layered on top, and current market ranges sit roughly between $140,000 and $190,000 base plus superannuation, vehicle or allowance and bonus, with senior and therapeutic-area lead roles above that.

It is the most asked-about career pivot in the industry, from the lab bench, the pharmacy and the clinic alike, and most of what candidates read about it online is written for the American market. This is the Australian version.



What the role actually involves

The centre of the job is scientific exchange: sitting with a specialist and discussing trial data, mechanisms and emerging evidence as a peer, not a promoter. Around that centre orbit the rest: supporting investigator-initiated research and trial site relationships, gathering field insights that feed medical strategy, training internal teams on the science, presenting at advisory boards and congresses, and responding to unsolicited clinical questions with balanced evidence. The split matters legally and culturally: MSLs sit in medical affairs, separate from sales, and the non-promotional line is governed by industry codes and taken seriously. A good MSL is measured on the quality of scientific relationships and insights, not on prescriptions.

The lifestyle is field-based: a territory of hospitals and academic centres, regular travel including interstate for congresses, and calendars built around clinicians' availability, which means early mornings and the occasional evening event. Autonomy is high, structure is low, and the role rewards people who can run their own week.


Requirements: do you need a PhD?

In Australia, a PhD is the most common credential and the safest signal, but it is not an absolute rule the way much overseas content suggests. Pharmacists, medical doctors, and masters-qualified scientists with strong clinical or research depth are hired regularly, particularly when they bring therapeutic-area expertise a team needs right now. What is genuinely non-negotiable is the ability to hold a peer-level scientific conversation with a specialist: the credential is a proxy for that, and interviews test the real thing, commonly through a data presentation exercise where you are handed a paper and asked to present and defend it.

The strongest transitions we see: postdocs and research scientists with communication flair, hospital and industry pharmacists, clinical trial professionals moving from site or CRO roles, and experienced pharma professionals deepening into medical affairs. What each pivot needs to demonstrate is the missing half: scientists prove they can engage commercially aware stakeholders; commercial people prove scientific depth.


The interview reality

MSL interviews are unusually predictable in format and unusually demanding in standard. Expect the data presentation: a published paper, sometimes provided in advance and sometimes on the day, presented to a panel playing sceptical clinicians. What is being tested is not memorisation but behaviour under scientific pressure: balance, honesty about limitations, and the ability to say “the data does not answer that” without flinching. Candidates who treat the exercise as a peer discussion rather than a performance pass it; candidates who oversell do not, because overselling is precisely what the role must never do.


Getting in, and what it pays

Entry MSL roles exist but are contested, so the practical routes run through adjacency: medical information, clinical research, and therapeutic-area alignment, since companies hire fastest when your science matches their portfolio, oncology for oncology, immunology for immunology. Salaries scale with experience and therapeutic area; the ranges above reflect the current market, with the full breakdown by function in our salary benchmarks and industry trends report. MSL vacancies move through specialist channels more than job boards, which is exactly why registering matters: our pharmaceutical recruitment team occasionally works medical affairs briefs, and if there are live roles they will sit on the healthcare jobs board.


Frequently asked questions

What does a medical science liaison do?

Builds peer-to-peer scientific relationships with key opinion leaders and clinicians, exchanges evidence non-promotionally, supports research, and feeds field insights back into medical strategy.

How do I become an MSL in Australia?

Bring strong postgraduate science or clinical credentials, therapeutic-area depth, and proven scientific communication, then enter directly or through adjacent roles in medical information or clinical research.

What is the salary of a medical science liaison in Australia?

Typically $140,000 to $190,000 base plus super, vehicle and bonus at the establishment level, rising for senior and lead roles. Treat figures as current market guides and see the salary report for detail.

Do you need a PhD to be an MSL?

It is the most common credential in Australia but not an absolute requirement; pharmacists, doctors and masters-qualified scientists with real depth are hired regularly. Peer-level scientific fluency is the true gate.

Thinking about the pivot? Submit your resume with your therapeutic area front and centre; in medical affairs, the science match is what moves first.


From our blog

View our blogs and webinar recordings for insights into recruitment in the healthcare industry, company culture and to hear from senior leaders in the healthcare industry on what they are doing in their organisations, along with tips on landing your dream job.

By Elizabeth Pettit September 14, 2026
What an employee value proposition is, the five components it is built from, and what actually moves candidates in Australian pharma and medtech specifically.
By Elizabeth Pettit September 14, 2026
A factual map of the pharmaceutical and medical device companies operating in Australia, where they are headquartered, and what that means for your career.
By Elizabeth Pettit September 14, 2026
Worked STAR method examples for healthcare, pharma and medtech interviews: territory sales, clinical monitoring and regulatory deadlines, with the method itself.
By Elizabeth Pettit September 14, 2026
A ninety-day plan after redundancy in pharma or medtech: stabilise, rebuild your resume, run the search like a job, and what an outplacement service actually is.
By Elizabeth Pettit September 14, 2026
Most medtech executive searches run around twelve weeks from brief to signed offer. Where that time goes, why it stretches, and what genuinely speeds it up.
By Elizabeth Pettit September 14, 2026
A bad hire costs 15-21% of salary, but in medtech it compounds faster. What hiring mistakes really cost, and the practical steps that keep the odds in your favour.
Show More